Extended Interval Dosing of Gentamicin in Neonates
Key facts
- Who runs it
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 42 people, planned
- Started
- 17 Jun 2026
- Expected to end
- Apr 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Standard of care administration of gentamicin dosed at 3 mg/kg every 24 hours
- Standard of care administration of gentamicin dosed at 3.5 mg/kg every 24 hours
- Record updated
- 1 October 2026
Who can take part
- Age
- 0 days to 7 days
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (7)Hide the full registry criteria
Who can take part
- Neonates up to 7 days of age,
- Neonate must be on gentamicin, and
- Gentamicin trough and peak levels must be available for the third dose of gentamicin
Who cannot take part
- On other nephrotoxic or ototoxic drugs concurrently with the first 3 days of gentamicin
- Baseline renal dysfunction (e.g. congenital kidney disease)
- Incorrect dose for weight (+/- 10% allowed to account for dose rounding)
- Multiple levels from the same patient; only the first set of levels will be collected
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Early onset sepsis
This trial is currently available in Canada.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A previous pharmacy residency project was done 20 years ago looking at the best dosing for the antibiotic gentamicin for babies up to 7 days old. This study showed that giving the dose less often leads to better drug concentrations than giving the dose more often. Our gentamicin dosing at the Children's Hospital at London Health Sciences Centre is based on the better dosing from the study. This dosing is gentamicin 3 mg/kg every 24 hours for babies less than 35 weeks gestational age and 3.5 mg/kg every 24 hours for babies at least 35 weeks gestational age. These results were never published. Different dosing is used at different hospitals. It is important that we check that our gentamicin dosing is still reaching safe and effective drug concentrations in the current study. The study will look at the gentamicin drug concentrations of babies up to 7 days old, including premature and term babies. We will also confirm if the babies have kidney or hearing damage from gentamicin. We will compare the gentamicin drug concentrations from this study to the past data to see if the dosing is still the best. The results can help form a guideline for the Children's Hospital and surrounding hospitals.
The 2 groups in the trial
- Neonates less than 35 weeks gestational age
Treatment: Standard of care administration of gentamicin dosed at 3 mg/kg every 24 hours
- Neonates at least 35 weeks gestational age
Treatment: Standard of care administration of gentamicin dosed at 3.5 mg/kg every 24 hours
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Extended Interval Dosing of Gentamicin in Neonates to Achieve Target Drug Concentrations
- Criteria questions
- Built from NCT07460349, who can take part
- Record updated
- 1 October 2026